Answers are grounded in this paper and cite their sources.
The use of rocuronium and sugammadex in patients with undiagnosed myasthenia gravis may result in postoperative respiratory failure due to incomplete reversal of neuromuscular blockade.
Myasthenia gravis (MG) is an autoimmune disease caused by the development of antibodies against the nicotinic acetylcholine receptor. There is hypersensitivity against non-depolarizing muscle relaxants in these patients. Sugammadex eliminates the effects of steroid non-depolarizing muscle relaxants, such as rocuronium and vecuronium, by selectively encapsulating their molecules. In this case report, we present a case of recurarization and respiratory failure after the use of sugammadex and rocuronium in a patient with preoperatively undiagnosed myasthenia gravis.
No takes yet. Share an insight, caveat, or question.
Ozel et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: